DrugsControl Media Services
DrugsControl.org

News Detail

MHRA disallows epilepsy drug Topiramate use for pregnant patients (21-06-2024)

London, 21 June 2024: The UK Medicines and Healthcare products Regulatory Agency (MHRA) is introducing new safety measures for topiramate after a study has shown an increased risk of neurodevelopmental disabilities in children whose mothers took the drug during pregnancy.  View Details

Source : Pharmaceutical Technolgy
UK Medicines and Healthcare products Regulatory Agency MHRA topiramate

Related News